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The erythrocytes of certain human individuals undergo a reversible 
change in shape known as sickling if deprived of oxygen (1, 2). Talia- 
ferro and Huck (3) postulated that this characteristic is transmitted by a 
single dominant gene, but failed to account genetically for the wide diver- 
gence in clinical signs and symptoms among individuals who possess sick- 
ling red cells. A small fraction, about 1 in 40, of these individuals have 
a severe chronic anemia called sickle-cell anemia; the others have no symp- 
toms which can be associated with this erythrocyte characteristic, and 
their condition is termed sickle-cell trait or sicklemia (4). Neel (5) has 
postulated that there exists in the Negro population a gene which in the 
heterozygous condition results in sicklemia and in the homozygous condi- 
tion in sickle-cell anemia. His statement is based on the finding that the 
trait was present in every parent of a sickle-cell anemia patient that he 
tested. This hypothesis is in accord with the results of recent electro- 
phoretic studies of the hemoglobins in these conditions (6, 7). These 
studies showed that the erythrocytes of individuals with sickle-cell anemia 
contain a new kind of hemoglobin, different from that of normal individ- 
uals, and also that the hemoglobin of sicklemic persons consists of two 
components which behave electrophoretically as normal hemoglobin and 
sickle-cell anemia hemoglobin. These results have aided in the clarifica- 
tion of both the genetic and the clinical aspects of sickle-cell anemia and 
sickle-cell trait. In the attempt to obtain information about the nature 
of sickle-cell anemia hemoglobin, amino acid analyses of hydrolysates of 
normal, human, adult hemoglobin and of sickle-cell anemia hemoglobin 
were carried out, which showed that there are probably small differences 
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in the number of residues of leucine, serine, valine, and threonine in these 
molecules (8). 
It has been observed that all of the erythrocytes of individuals with 
sickle-cell trait undergo sickling and that a greater reduction in partial 
pressure of oxygen is required to produce complete sickling in sickle-cell 
trait erythrocytes than in those of sickle-cell anemics (1). These obser- 
vations indicate that each sicklemia erythrocyte contains both normal 
hemoglobin and sickle-cell anemia hemoglobin. In a pooled sample of 
blood from five sicklemic individuals the ratio of t,he abnormal to the nor- 
mal hemoglobin was found to be 39:61 (7). 
In the light of this knowledge it was considered pertinent to ascertain 
the extent of the variation of the ratio of sickle-cell anemia hemoglobin 
(SCA hemoglobin) to normal hemoglobin in sicklemic individuals and the 
effect of various factors on this ratio. Such information not only would 
increase the knowledge of sickle-cell disease but also might shed some 
light on the general problem of the control of hemoglobin anabolism. 
EXPERIMENTAL 
Blood Samples-Samples of blood to which either citrate or oxalate had 
been added were obtained from parents of sickle-cell anemic children or 
from brothers or sisters of sickle-cell anemic individuals and were kept at 
4” until solutions of hemoglobin could be prepared from them.’ Qther sam- 
ples were obtained in examining the cell residues of blood obtained from 
Negro donors at a commercial blood bank.2 For this purpose the rapid 
diagnostic test of Itano and Pauling (9) was employed, and samples of 
those cell residues which responded positively to this test were stored as 
noted above. As far as it was possible to determine, these persons were 
otherwise normal and had not received a blood transfusion within a year 
previous to the time the blood or cell samples were obtained. 
Solutions of hemoglobin were prepared from these samples of blood and 
erythrocytes according to the method of Drabkin (10). The hemoglobin in 
each solution was converted to the carbonmonoxy derivative by saturating 
the solutions with carbon monoxide and each solution was then stored at 
4” in tightly stoppered, brown glass bottles. The hemoglobin concentra- 
tion of each solution was determined spectrophotometrically at 540 mp. 
For this purpose a Coleman junior spectrophotometer was used and the 
standard curve employed was obtained by using a pure solution of normal 
1 We are indebted to Dr. George E. Burch of Tulane University School of Med- 
icine, New Orleans, to Dr. Robert A. Blossom of the Los Angeles County General 
Hospital, to Dr. Phillip Sturgeon of the Children’s Hospital, Los Angeles, and to 
Dr. J. V. Neel of the University of Michigan, Ann Arbor, for samples of whole blood. 
2 Hyland Labornt,ories, Los Angeles, California. 
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carbonmonoxyhemoglobin, the concentration of which had been deter- 
mined by iron analysis (8). 
Electrophoresis Experiments-The electrophoresis experiments carried out 
in this investigation were very similar to those previously described (7). 
The buffer solution used consisted of 0.08 M NaC1, 0.02 M sodium cacody- 
late, and 0.008 M cacodylic acid and had a pH of 6.50 and ionic strength 
of 0.10 (11). A portion of each hemoglobin solution was diluted to a 
concentration of 1 per cent with buffer and then dialyzed at 4’ for 18 hours 
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FIG. 1. The ascending and descending boundaries of an electrophoresis experi- 
ment on the carbonmonoxyhemoglobin from a typical sicklemie individual. The 
leading peak is due to SCA hemoglobin. In some experiments, including those on 
known mixtures of SCA hemoglobin and normal hemoglobin, extraneous spikes have 
occurred in the descending boundary. The cause of this difficulty is undetermined; 
however, no such effects ever occur in the ascending boundary under the conditions 
used for electrophoresis. 
against the buffer saturated with carbon monoxide. Finally the dialyzed 
solutions were completely clarified by centrifugation in the cold at 36,500 
X g for 20 minutes and then subjected to electrophoresis for 15 hours 
under a potential gradient of 3.57 volts per cm., with the equipment pre- 
viously described (7). 
In Fig. 1 are shown typical Longsworth scanning diagrams of an elec- 
trophoresis experiment on a hemoglobin sample from a sicklemic individ- 
ual. Under the conditions used for electrophoresis, the descending bound- 
ary is much more diffuse than the ascending one; therefore, the latter 
boundary was chosen for measurement. 
The image of the ascending boundary was projected and enlarged by 
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means of a photographic enlarger and traced on a large piece of paper. 
Routinely, six tracings were made in order to minimize the subjective 
errors. Since the leading and trailing edges of the boundary are not sym- 
metrical, the two peaks were resolved by means of the method of Tiselius 
and Kabat (12) of dropping a perpendicular to the base-line from the 
minimum point between the two peaks. The total area under the curve 
and the area under the SCA hemoglobin peak were measured for each 
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FIG. 2. Ascending boundaries of electrophoresis experiments on the carbonmon- 
oxyhemoglobin from some individual sicklemics. The leading peak is due to SC.4 
hemoglobin. 
tracing with a planimeter. After the average value for each quantity was 
determined, the “measured” percentage of SCA hemoglobin in the sample 
was calculated. In order to convert this measured percentage to the 
actual percentage a calibration curve was used, which was made in the 
following manner. Known mixtures of normal and SCA hemoglobin, hav- 
ing a total protein concentration of 1 per cent, were subjected to electro- 
phoresis under the conditions already described for sicklemia hemoglobin. 
The ascending boundaries were treated as above and the measured per- 
centages of SCA hemoglobin were plotted against the known percentages 
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(7). The equation of the linear curve thus obtained, calculated by means 
of the method of least squares, is Y = 1.17 X - 5.5, where Y is the actual 
percentage of SCA hemoglobin and X is the measured percentage. 
The measured percentage of SCA hemoglobin from an electrophoresis 
experiment of a sample of sicklemia hemoglobin, as described above, is 
substituted in the equation of the calibration curve and the actual percent- 
age of SCA hemoglobin in the sample calculated. 
Typical Longsworth scanning diagrams of the ascending boundaries of 
electrophoresis experiments of samples of hemoglobin from individual 
sicklemics are reproduced in Fig. 2. It is obvious that there are significant 
differences in the percentages of SCA hemoglobin among these samples. 
It was of importance t.o ascertain how reproducible were the results of 
any one experiment.. To achieve this end the electrophoretic analyses of 
two samples were repeated. The percentages of SCA hemoglobin from 
the separate runs for each sample taken from sicklemic individuals were 
as follows: Case 25, 29.7 per cent, 28.9 per cent; Case 33, 34.1 per cent, 
32.7 per cent. It is felt that the results of any one determination are 
probably reproducible to about f 1.5 per cent. 
Results 
In Table I there are presented the results obtained from forty-two 
sicklemic individuals. These persons were chosen at random, as is indi- 
cated in the section above in which the procurement of samples is dis- 
cussed, the only restriction being that the individuals should not be geneti- 
cally related. Even though the names of the twelve donors obtained from 
the commercial blood bank were different, these samples offer some un- 
certainty in this latter respect. 
In these forty-two sicklemic individuals the per cent of SCA hemoglobin 
ranged from about 24 to about 45 per cent, with an arithmetic mean of 
37.5 per cent. It is to be noted that one-third of the samples contained 
between 40 and 42 per cent of SCA hemoglobin. An increased frequency 
appears to be present at about 34 per cent of SCA hemoglobin; however, 
the small number of samples makes this trend of doubtful significance. 
Because of the wide range of percentages found, as many factors as pos- 
sible have been studied in an attempt to establish their influence on the 
ratio of SCA hemoglobin to normal hemoglobin in sicklemic individuals. 
Effect of Time-Fortunately it was possible to obtain, after variable 
periods of time had elapsed, new samples of blood from sicklemic individ- 
uals whose percentage of SCA hemoglobin had been previously deter- 
mined. The results of these determinations are shown in Table II. It 
is seen that some of the final percentages are greater and some are less 
than the initial percentages. Undoubtedly some part of these differences 
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is due to inherent errors of the method used for measurement and some is 
due to physiological variation. Presumably the normal and SCA hemo- 
globins in a healthy sicklemic individual are in a state of dynamic equilib- 
TABLE I 
Hemoglobin in Sickle-Cell Trait 
Case No. 
11 
67 
64 
25 
12 
80 
4 
33 
35 
66 
83 
46 
71 
56 
28 
49 
M. H. 
8 
5 
34 
65 
Sex 
F. 
“ 
“ 
F. 
“ 
M. 
‘I 
F. 
‘I 
M. 
“ 
F. 
M. 
F. 
“ 
M. 
F. 
‘I 
M. 
AS 
38 
32 
44 
41 
24 
35 
65 
30 
25 
1 
SCA 
vznoglobin 
fw cent 
24.3 
27.7 
27.9 
29.4 
32.3 
33.1 
33.3 
33.4 
33.7 
33.9 
34.0 
34.3 
34.4 
35.1 
35.2 
35.6 
36.6 
37.1 
37.5 
37.5 
38.2 
Case No. 
111 
37 
30 
10 
29 
93 
36 
101 
26 
75 
B. M. S. 
7 
39 
47 
91 
110 
31 
15 
98 
57 
63 
- 
Sex 
F. 
M. 
“ 
F. 
‘I 
F. 
“ 
M. 
“ 
F. 
F. 
‘I 
M. 
F. 
“ 
M. 
“ 
“ 
34 
23 
10 
38 
12 
TABLE II 
Constancy of Per Cent SCA Hemoglobin with Time 
1 
- 
SCA 
hemoglobin 
per cent 
38.9 
39.9 
40.0 
40.4 
40.5 
40.5 
40.9 
40.9 
41.0 
41.0 
41.0 
41.1 
41.3 
41.3 
41.5 
41.6 
42.4 
42.6 
43.9 
44.5 
45.2 
Case No. SCA hemoglobin 
I 
Difference 
15 
25 
7 
4 
5 
per cent per cent 
42.6, after 2 mths. 41.3 -1.3 
29.3, (( 2f d( 31.7 +2.4 
42.0, “ 3 “ 39.8 -2.2 
33.3, (‘ 4 “ 32.7 -0.6 
37.5, “ 4 “ 40.1 +2.6 
rium with their precursors and catabolic products (13) and small fluctua- 
tions of the ratio of the two hemoglobins around a mean value are to be 
expected. With these considerations in mind it is concluded that the 
above data support the idea that the ratio of SCA hemoglobin to normal 
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hemoglobin is relatively constant in a sicklemic individual, at least for 
periods as long as 4 months. 
Efect of Age and Sex-In Table I there are given the age and sex of 
some of the sicklemic individuals from whom samples of blood were ob- 
tained. It is immediately apparent that both sexes have percentages 
occurring throughout the range of variation demonstrated above and that 
there is no grouping with respect to age. Consequently, the conclusion 
has been drawn that these two variables have no effect on the ratio of the 
two hemoglobins. It is of interest that the total hemoglobin level, which 
normally is different in the two sexes, apparently has no influence on the 
ratio of the two hemoglobins. 
E$ect of Environment-As previously indicated, the persons from whom 
samples of blood were obtained for use in this study live in widely sepa- 
rated regions, i.e., Los Angeles, California, New Orleans, Louisiana, and 
TABLE III 
R61e of Heredity in SCA Hemoglobin 
Case No. I Family relationship I SCA hemoglobin 
per cent 
38 Mother 41.3 
71 Father 34.4 
42 Daughter 40.1 
43 Son 40.2 
Ann Arbor, Michigan. As is to be expected, persons from any one of 
these regions do not have a characteristic ratio of the two hemoglobins, 
but rather their ratios fall throughout the range of variation. An even 
closer scrutiny of the effect of this complex variable is afforded by the oc- 
currence of six cases of husband and wife among the forty-two sicklemic 
cases mentioned above. The percentages of SCA hemoglobin found in 
these cases are as follows: 34.4, 42.6; 34.3, 41.3; 44.5, 35.1; 38.2, 27.9; 
41.0, 40.5; 41.6, 38.9. Thus, with these sicklemic individuals, who are 
affected largely by the same environment, the percentages of SCA hemo- 
globin may be either the same or different. 
Owing to the nature of this study it has not been possible to assay the 
effect of diet on the ratio of the two hemoglobins in sicklemics. How- 
ever, since there is no known dietary therapy for sickle-cell anemia, it is 
considered to be unlikely that the variation of the ratio of the two hemo- 
globins could be traced to a dietary cause. 
Influence of Heredity-Since sickle-cell anemia has been shown to be an 
inherited condition (5), it is not unimportant to assess the role heredity 
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may play in determining the percentage of SCA hemoglobin a sicklemic 
person may have. 
The data in Table III indicate that heredity may be the major factor 
which determines the percentage of SCA hemoglobin occurring in a sick- 
lemic person. In this family, the percentages of SCA hemoglobin which 
the parents have are quite different, and the percentages of the two sick- 
lemic children (another child was a sickle-cell anemic) are the same and 
correspond to that of the mother instead of being intermediate between 
the percentage of the father and that of the mother or not corresponding 
with the percentage of either parent. If these results are considered with 
respect to t,he single gene hypothesis (5), they suggest that the children 
may have inherited the mother’s allele for sickling and that this particular 
allele resuhs in a characteristic proportion of SC-4 hemoglobin. 
DISCUSSION 
In view of the results of previous investigations (5-7), it is perhaps to be 
expected that heredity may be the dominant factor determining the rat,io 
of SCA hemoglobin to normal hemoglobin in sicklemic individuals. While 
both the electrophoretic and genetic evidence is in agreement as to the 
qualitative aspects of the transmission of sickle-cell anemia and sickle-cell 
trait, the variation of the data exhibited in Table I and the clinical obser- 
vation that, gradations occur in the severity of the disease in sickle-cell 
anemia (14) imply that the simple hypothesis of Keel (5) must be extended 
and amplified in order to explain the quantitative aspect,s of sickle-cell 
disease. One might consider the possibi1it.y that the rates of production 
of both normal and SCA hemoglobins are subject to independent modifica- 
tion by other factors. The rate of production of hemoglobin in a sickle- 
cell anemic and the ratio of t,he two hemoglobins in an individual having 
a sickle-cell trait may be dependent on the modifying factors present in 
the individual, on the particular allelic form of the gene he possesses, or 
on undisclosed elements of his environment. 
Anomalous Sickle-Cell Anemics 
During the course of this work it became necessary to examine electro- 
phoretically samples of hemoglobin obtained from a series of sickle-cell 
anemics. Among the members of this series there were some who had 
been able, without apparent difficulty, to exist without t,he need of blood 
transfusions for well over a year. A possible explanation for this behavior 
in three of these cases presented itself when the electrophoretic patt.erns 
of the hemoglobin from these persons revealed the presence of varying 
amounts of normal hemoglobin. Fig. 3 contains reproductions of Longs- 
worth scanning diagrams of the ascending boundaries of electrophoret’ic 
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experiments on the hemoglobin of these three persons. Case 22 had not 
received a transfusion with normal blood for over a year before the first 
blood sample was obtained; a second blood sample obtained 6 months after 
the first revealed that normal hemoglobin was still present, even though 
no normal blood had yet been transfused. These patterns are similar to 
those obtained from sickle-cell anemics at varying lengths of time after 
transfusion with normal blood. 
Individuals such as these may be classified as border line sickle-cell ane- 
mics; their ability to produce significant amounts of normal hemoglobin 
- 
FIG. 3. Ascending boundaries of electrophoresis experiments on the carbonmon- 
oxyhemoglobin from some anomalous sickle-cell anemics. The conditions used for 
electrophoresis were the same as t,hose employed for the sicklemic samples. The 
leading peak is due to SCA hemoglobin. In these cases the normal hemoglobin con- 
stitutes 5 to 20 per cent of the total. 
probably account,s for their improved level of existence, since the charac- 
teristics of their erythrocytes would be intermediate between those of 
sicklemia and sickle-cell anemia erythrocytes. The former are known to 
have a survival time both in normal and sickle-cell anemic individuals 
equal to that of normal erythrocytes (15-17). 
It is felt that here is fundamental evidence to support the long held 
clinical feeling that “. . . all shades of variation between the trait and se- 
vere anemia may be encountered though no adequate evidence has been 
offered” (14). 
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The role of heredity of such cases is unclear, since the investigation of 
the parents of two of these persons revealed that they were typical sickle- 
mics: Case 22, father 41.0, mother 40.5; Case 45, father 44.5, mother 35.1 
per cent of SCA hemoglobin. Further investigation is necessary to ex- 
plain these cases. 
SUMMARY 
The ratio of sickle-cell anemia hemoglobin to normal hemoglobin has 
been determined in forty-two sicklemic individuals who were otherwise 
normal and genetically unrelated. In this series of individuals the SCA 
hemoglobin varied from about 24 to 45 per cent. 
Of the several factors tested, i.e., time, age, sex, some environmental fac- 
tors, and heredity, the latter is the only one not excluded as having an 
appreciable influence on the ratio of the two hemoglobins which occurs 
in a sicklemic person. 
The discovery of some anomalous cases of sickle-cell anemia is reported. 
In contrast to the true sickle-cell anemic, these individuals are able to 
produce small amounts of normal hemoglobin. 
The authors take pleasure in acknowledging their indebtedness to Dr. 
Linus Pauling for his many suggestions and careful reading of the manu- 
script, to Dr. J. V. Neel of the University of Michigan, Ann Arbor, Michi- 
gan, and to Dr. Ray D. Owen, of the Biology Division of this Institute, 
for their helpful suggestions. 
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